These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6592097)

  • 1. Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man.
    McGivern DV; Basran GS
    Eur J Pharmacol; 1984 Jun; 102(1):183-5. PubMed ID: 6592097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man.
    Archer CB; Frohlich W; Page CW; Paul W; Morley J; MacDonald DM
    Prostaglandins; 1984 Mar; 27(3):495-501. PubMed ID: 6203139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin.
    Archer CB; Page CP; Paul W; Morley J; MacDonald DM
    Br J Dermatol; 1984 Jan; 110(1):45-50. PubMed ID: 6581831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor-acether-induced relaxation of guinea pig airway muscle: role of prostaglandin E2 and the epithelium.
    Brunelleschi S; Haye-Legrand I; Labat C; Norel X; Benveniste J; Brink C
    J Pharmacol Exp Ther; 1987 Oct; 243(1):356-63. PubMed ID: 3478474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin.
    Morley J; Page CP; Paul W
    Br J Pharmacol; 1983 Nov; 80(3):503-9. PubMed ID: 6685552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory characteristics of PAF-acether in the skin of experimental animals and man.
    Archer CB; Page CP; Paul W; Morley J; MacDonald DM
    Int J Tissue React; 1985; 7(5):363-5. PubMed ID: 3863807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma.
    Basran GS; Morley J; Paul W; Turner-Warwick M
    Lancet; 1982 Apr; 1(8278):935-7. PubMed ID: 6122773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed-onset synergism between leukotriene B4 and prostaglandin E2 in human skin.
    Archer CB; Page CP; Juhlin L; Morley J; MacDonald DM
    Prostaglandins; 1987 Jun; 33(6):799-805. PubMed ID: 2823313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of prostaglandin E2 and its 16,16-dimethyl analogue to prevent the gastric mucosal damage induced by Paf.
    Steel G; Wallace JL; Whittle BJ
    Br J Pharmacol; 1987 Feb; 90(2):365-71. PubMed ID: 3470106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
    Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
    J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between PAF-acether and drugs that stimulate cyclic AMP in guinea-pig alveolar macrophages.
    Bachelet M; Adolfs MJ; Masliah J; Bereziat G; Vargaftig BB; Bonta IL
    Eur J Pharmacol; 1988 Apr; 149(1-2):73-8. PubMed ID: 2840303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021.
    Rola-Pleszczynski M; Pignol B; Pouliot C; Braquet P
    Biochem Biophys Res Commun; 1987 Feb; 142(3):754-60. PubMed ID: 3493773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man.
    Archer CB; MacDonald DM; Morley J; Page CP; Paul W; Sanjar S
    Br J Pharmacol; 1985 May; 85(1):109-13. PubMed ID: 2862936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin.
    Fjellner B; Hägermark O
    Acta Derm Venereol; 1985; 65(5):409-12. PubMed ID: 2416164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activating factor and the responses of rat isolated stomach strip to prostaglandin E2.
    Izzo AA; Mascolo N; Autore G; Capasso F
    J Pharm Pharmacol; 1993 Aug; 45(8):761-2. PubMed ID: 7901378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory effects of platelet activating factor (PAF) in equine skin.
    Foster AP; Cunningham FM; Lees P
    Equine Vet J; 1992 May; 24(3):208-14. PubMed ID: 1606934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability.
    Brain SD; Williams TJ
    Br J Pharmacol; 1985 Dec; 86(4):855-60. PubMed ID: 2416378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of prostaglandins and PG-analogues on the mortality of PAF-acether in mice and the TXB2 release from human granulocytes.
    Becker K; Förster W
    Biomed Biochim Acta; 1988; 47(10-11):S169-72. PubMed ID: 3248104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of prostaglandin E2 in endotoxic shock are unrelated to effects on PAF-acether synthesis.
    Ibbotson GC; Wallace JL
    Prostaglandins; 1989 Feb; 37(2):237-50. PubMed ID: 2727308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.